Literature DB >> 19582476

Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma.

Thidarut Boonmars1, Zhiliang Wu, Sirintip Boonjaruspinyo, Somchai Pinlaor, Isao Nagano, Yuzo Takahashi, Butsara Kaewsamut, Puangrat Yongvanit.   

Abstract

Opisthorchiasis has the significant relationship with the high prevalence of cholangiocarcinoma (CCA; a bile duct cancer) in the endemic areas in Southeast Asia. To reveal the molecular mechanism of the tumorigenesis induced by Opisthorchis viverrini infection, the present study investigated the kinetic expression of RB pathway genes, including RB1, p16(INK4), cyclin D1, and CDK4, during the development of opisthorchiasis-associated CCA in hamster model. The results of quantitative real-time polymerase chain reaction indicated that the expressions of RB1 and p16(INK4) were down-regulated during the development of CCA induced by infection plus N-nitrosodimethylamine treatment in a time-dependent manner. On the other hand, the expressions of cyclin D1 and CDK4 were up-regulated. The expression kinetics was corresponding to the pathological progression of the opisthorchiasis-associated CCA, revealed by histopathological observation. Moreover, the analysis of the expression of these genes in human opisthorchiasis-associated CCA cases showed the decreased expression of RB1 and p16(INK4) in 50% and 82.7% cases and overexpression of cyclin D1 and CDK4 in half cases, respectively. The results suggested that RB pathway is likely involved in the tumorigenesis of opisthorchiasis-induced CCA and proposed the potential application of some of these genes as biomarkers in predispose and molecular therapy of the parasite-associated cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582476     DOI: 10.1007/s00436-009-1548-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  49 in total

Review 1.  Perturbation of cell cycle regulators in human cancer.

Authors:  I Palmero; G Peters
Journal:  Cancer Surv       Date:  1996

Review 2.  Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand.

Authors:  C Pairojkul; T Shirai; S Hirohashi; W Thamavit; W Bhudhisawat; T Uttaravicien; M Itoh; N Ito
Journal:  Princess Takamatsu Symp       Date:  1991

3.  Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.

Authors:  H Azechi; N Nishida; Y Fukuda; T Nishimura; M Minata; H Katsuma; M Kuno; T Ito; T Komeda; R Kita; R Takahashi; K Nakao
Journal:  Oncology       Date:  2001       Impact factor: 2.935

Review 4.  Molecular prognostic markers in pancreatic cancer: a systematic review.

Authors:  G Garcea; C P Neal; C J Pattenden; W P Steward; D P Berry
Journal:  Eur J Cancer       Date:  2005-09-16       Impact factor: 9.162

5.  Apoptosis-related gene expressions in hamsters re-infected with Opisthorchis viverrini and re-treated with praziquantel.

Authors:  T Boonmars; T Srisawangwong; P Srirach; B Kaewsamut; S Pinlaor; P Sithithaworn
Journal:  Parasitol Res       Date:  2007-09-13       Impact factor: 2.289

Review 6.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

7.  Defining a molecular phenotype for benign and malignant parathyroid tumors.

Authors:  Gustavo G Fernandez-Ranvier; Elham Khanafshar; David Tacha; Mariwil Wong; Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  Cancer       Date:  2009-01-15       Impact factor: 6.860

8.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

9.  Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.

Authors:  Andrea Tannapfel; Florian Sommerer; Markus Benicke; Lars Weinans; Alexander Katalinic; Felix Geissler; Dirk Uhlmann; Johann Hauss; Christian Wittekind
Journal:  J Pathol       Date:  2002-08       Impact factor: 7.996

10.  Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.

Authors:  Sunanda J Chatterjee; Ram Datar; David Youssefzadeh; Ben George; Peter J Goebell; John P Stein; Lillian Young; Shan-Rong Shi; Conway Gee; Susan Groshen; Donald G Skinner; Richard J Cote
Journal:  J Clin Oncol       Date:  2004-02-23       Impact factor: 44.544

View more
  10 in total

1.  Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Sasithorn Kaewkes; Porntip Laummaunwai; Somchai Pinlaor; Watchalin Loilome; Puangrat Yongvanit; Zhiliang Wu; Anucha Puapairoj; Vajarabhongsa Bhudhisawasdi
Journal:  Pathol Oncol Res       Date:  2011-07-13       Impact factor: 3.201

2.  Comparative studies on animal models for Opisthorchis viverrini infection: host interaction through susceptibility and pathology.

Authors:  Orasa Wonkchalee; Thidarut Boonmars; Sasithron Kaewkes; Yaovalux Chamgramol; Chantana Aromdee; Zhiliang Wu; Amornrat Juasook; Pakkayanee Sudsarn; Sirintip Boonjaraspinyo; Chawalit Pairojkul
Journal:  Parasitol Res       Date:  2011-09-01       Impact factor: 2.289

3.  Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma.

Authors:  Zhiliang Wu; Thidarut Boonmars; Isao Nagano; Watcharin Loilome; Puangrat Yongvanit; Narong Khuntikeo; Phuangphaka Sadee Nielsen; Chawalit Paorojkul; Yuzo Takahashi; Yoichi Maekawa
Journal:  Tumour Biol       Date:  2014-03

4.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

5.  Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.

Authors:  Sirintip Boonjaraspinyo; Thidarut Boonmars; Zhiliang Wu; Watcharin Loilome; Paiboon Sithithaworn; Isao Nagano; Somchai Pinlaor; Puangrat Yongvanit; Phuangphaka Sadee Nielsen; Chawalit Pairojkul; Narong Khuntikeo
Journal:  Tumour Biol       Date:  2012-06-26

Review 6.  Hilar cholangiocarcinoma: pathology and tumor biology.

Authors:  Dong Kuang; Guo-Ping Wang
Journal:  Front Med China       Date:  2010-11-25

7.  Tumor-related gene changes in immunosuppressive Syrian hamster cholangiocarcinoma.

Authors:  Amornrat Juasook; Ratchadawan Aukkanimart; Thidarut Boonmars; Pakkayanee Sudsarn; Nadchanan Wonkchalee; Porntip Laummaunwai; Pranee Sriraj
Journal:  Pathol Oncol Res       Date:  2013-05-06       Impact factor: 3.201

8.  Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine.

Authors:  Md Hafiz Uddin; Min-Ho Choi; Woo Ho Kim; Ja-June Jang; Sung-Tae Hong
Journal:  PLoS Negl Trop Dis       Date:  2015-08-27

9.  Establishment of an allo-transplantable hamster cholangiocarcinoma cell line and its application for in vivo screening of anti-cancer drugs.

Authors:  Nattapong Puthdee; Kulthida Vaeteewoottacharn; Wunchana Seubwai; Orasa Wonkchalee; Worasak Kaewkong; Amornrat Juasook; Somchai Pinlaor; Chawalit Pairojkul; Chaisiri Wongkham; Seiji Okada; Thidarut Boonmars; Sopit Wongkham
Journal:  Korean J Parasitol       Date:  2013-12-31       Impact factor: 1.341

Review 10.  Parasite Infection, Carcinogenesis and Human Malignancy.

Authors:  Hoang van Tong; Paul J Brindley; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-12-02       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.